BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,758 | -20.5% | 35 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $2,212 | +40.4% | 35 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,575 | -29.5% | 35 | -31.4% | 0.00% | 0.0% |
| Q4 2022 | $2,234 | -25.5% | 51 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $3,000 | 0.0% | 51 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $3,000 | -40.0% | 51 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $5,000 | -28.6% | 51 | -29.2% | 0.00% | -25.0% |
| Q3 2021 | $7,000 | +16.7% | 72 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $6,000 | -14.3% | 72 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $7,000 | +16.7% | 72 | +30.9% | 0.00% | 0.0% |
| Q4 2020 | $6,000 | +50.0% | 55 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $4,000 | -42.9% | 55 | -42.7% | 0.00% | -20.0% |
| Q3 2019 | $7,000 | -30.0% | 96 | -8.6% | 0.01% | -28.6% |
| Q2 2019 | $10,000 | +25.0% | 105 | 0.0% | 0.01% | +16.7% |
| Q1 2019 | $8,000 | -11.1% | 105 | -5.4% | 0.01% | +50.0% |
| Q3 2018 | $9,000 | – | 111 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |